Phil Lorenz

Phil spearheads the development of the next generation of Life Science AI, including the EDEN foundation models. By leveraging BaseData, a proprietary atlas of 10 trillion DNA tokens, he is pioneering “programmable biology” to design novel therapeutics, such as synthetic gene-insertion tools and antibiotics. An Oxford-trained molecular geneticist and investor, he bridges massive-scale genomic data and generative AI, collaborating with NVIDIA and Anthropic to map the “microbial dark matter” of the planet.